Clinical Trial Update: Study of COLAL-PRED® in the Treatment of Moderate Acute Ulcerative Colitis [Phase 3]

View source ↗

Summary

Phase 3 trial of COLAL-PRED for moderate acute ulcerative colitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• COLAL-PRED

Snippet

Sponsor: Alizyme | Conditions: Ulcerative Colitis | Phase 3 | Status: COMPLETED